Theme: A Global Discussion on technologies, advances and challenges in Vaccines
Vaccines Congress 2017
Conference series LLC take pride to announce and invites all the participants from all over the world to attend “19th International Vaccines & B2B Congress ” which will be held during July 27-28, 2017 Chicago, USA, which includes Prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of the conference is "Discussion on technologies, advances and challenges related to Vaccines".
International Vaccines & B2BCongress hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their Travel Medicine and Vaccines or its sister publication Immunome Research. Conference series LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Track: 1 Infectious Diseases Types
The Diseases caused by germs and which may infect any part of the body are called Infectious Diseases. They can spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.
With the burgeoning response and grand success of Conference series LLC" takes the pride of announcing the grand commencement of International Conference on Travel Medicine & Vaccines scheduled during October 05-06, 2017 Chicago, USA.
Track: 2 Ebola, Arboviral diseases and Haemorrhagic Fever
Nine of the people contracted the disease outside the US and travelled into the country, either as regular airline passengers or as medical evacuees; of those nine, two died. Two people have contracted Ebola in the United States; both were nurses who treated an Ebola patient; both have recovered.Arbovirus is a term used to refer to a group of viruses that are transmitted by arthropod vectors. The word arbovirus is an acronym (ARthropod-BOrne virus).Symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last 3 or 4 days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and hemorrhagic fever may also occur.The word tibovirus (TIck-BOrne virus) is sometimes used to describe viruses transmitted by ticks, a superorder within the arthropods.
Track: 3 Business People Investment Meet
Entrepreneur is the organize of starting a business, typically a start-up company offering an innovative product, process or service. The entrepreneur perceives an promotion and often exhibits biases in taking the decision to exploit the opportunity. The exploitation of entrepreneurial a chance for promotion includes design actions develop a business plan, acquire the human, financial other required resources, and be responsible for its success or failure. Entrepreneurship may operate within entrepreneurship ecosystem which includes government programs and services that promotes entrepreneurs, entrepreneurship resource In recent years, "entrepreneurship" has been extended from its origins in for-profit businesses to include social entrepreneurship the concept of the political entrepreneur.
Track: 4 Immunization for Emerging and Communicable Diseases
Immunization is one of the most successful and cost-effective health interventions, preventing millions of deaths every year. From infants to seniors, immunization protects against diseases such as diphtheria, measles, pertussis, pneumonia, polio, rotavirus, rubella and tetanus. The benefits of immunization are increasingly being extended to adolescents and adults, providing protection against life-threatening diseases such as influenza, meningitis, and cancers. A communicable disease is one that is spread from one person to another through a variety of ways that include: contact with blood and bodily fluids; breathing in an airborne virus; or by being bitten by an insect.
Track: 5 Global policy/Regulations for Disease prevention and control
To prevent or reduce the burden of infectious diseases of public health importance. There is reduced incidence of infectious diseases of public health importance. There is reduced morbidity and mortality associated with infectious diseases of public health importance. There is increased public capacity to prevent and control infectious diseases. There is increased capacity on the part of all hospitals, long-term care homes (LTCHs), and other settings with risk of infections to prevent and control infectious diseases.
Track: 6 Global Trends in Emerging Infectious Diseases
An Infectious Disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance and public health issues due to unhygienic conditions.
Track: 7 Animal and Tick-borne Infections
Tick-borne diseases, which afflict humans and other animals, are caused by infectious agents transmitted by tick bites. Tick-borne illnesses are caused by infection with a variety of pathogens, including rickettsia and other types of bacteria, viruses, and protozoa. Because individual ticks can harbour more than one disease-causing agent, patients can be infected with more than one pathogen at the same time, compounding the difficulty in diagnosis and treatment. Currently (2015), there are 16 known tick-borne diseases of humans (four discovered since 2013). As the incidence of tick-borne illnesses increases and the geographic areas in which they are found expand, it becomes increasingly important that health workers be able to distinguish the diverse, and often overlapping, clinical presentations of these diseases.
Track: 8 Vaccines Against infectious & Non Infections diseases
Infection is the invasion of an organism's body tissues by disease-causing agents, their multiplication, and the reaction of host tissues to these organisms and the toxins they produce. Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection. using their immune system. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response.Among the vast varieties of microorganisms, relatively few cause disease in otherwise healthy individuals. Infectious disease results from the interplay between those few pathogens and the defenses of the hosts they infect. The appearance and severity of disease resulting from any pathogen, depends upon the ability of that pathogen to damage the host as well as the ability of the host to resist the pathogen.
Track: 9 Allergies and skin diseases - Vaccinations
Skin problems are among the most frequent medical problems in returned travellers. The largest case series of dermatologic problems in returned travellers from the Geo Sentinel Surveillance Network showed that cutaneous larva migrans, insect bites, and bacterial infections were the most frequent skin problems in ill travellers who sought medical care, making up 30% of the 4,742 diagnoses In another review of 165 travellers who returned to France with skin problems, cellulitis, scabies, and pyoderma led the list of skin conditions. These data are biased in that they do not include skin problems that were diagnosed and, in many cases, easily managed during travel or that were self-limited.
Track: 10 Malaria sickness in and Treatment
Malaria is caused by the protozoan parasite Plasmodium. Human malaria is caused by four different species of Plasmodium: P. falciparum, P. malaria, P. ovale and P. vivax. Humans occasionally become infected with Plasmodium species that normally infect animals, such as P. knowlesi. As yet, there are no reports of human-mosquitohuman transmission of such “zoonotic” forms of malaria. The malaria parasite is transmitted by female Anopheles mosquitoes, which bite mainly between dusk and dawn. Malaria is an acute febrile illness with incubation period of 7 days or longer. Thus, a febrile illness developing less than 1 week after the first possible exposure is not malaria.
Track: 11 Diarrhea and other Gastrointestinal Disorders
sometimes tourist diarrhoea or traveller’s dysentery, is a stomach and intestinal infection, and the most common illness affecting travellers. It is defined as three or more unformed stools passed by a traveller within a 24-hour period. It is commonly accompanied by abdominal cramps, nausea, and bloating. The diagnosis does not imply causative organism, but enter toxigenic Escherichia coli (ETEC) is the most common pathogen Bacteria are responsible for roughly 80% of cases; most of the rest are caused by viruses and protozoans. Although most travellers with TD recover within a few days with little or no treatment, symptoms can sometimes be severe enough to require medical intervention. In those who are immunocompromised or otherwise prone to serious infections, TD is a significant concern and occasionally even life-threatening.
Track: 12 Tuberculosis
Tuberculosis is a bacterial infection caused by a bacterium called Mycobacterium tuberculosis which spread through the lymph nodes and bloodstream to any organ in your body. It is most commonly found in the lungs which attack the lungs and it can also attack any part of the body such as the kidney, spine, and brain.
Track: 13 Rubella Vaccines
Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated.
Track: 14 Global Market on Infectious Diseases
Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Track: 15 Causes and Symptoms of Infectious Diseases
Infectious Diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.
ConferenceSeries Ltd Conferences invites all the participants from all over the world to attend “International Vaccines & B2B Congress” during July 27-28, 2017 Chicago, USA . which includes explicit Keynote presentations, plenary talks from highly distinguished scientific staff, Poster presentations from talented student communities from Universities and Research labs and Exhibitions from Industries and companies in the vaccine and pharmaceutical sectors.
With the burgeoning response and grand success of ConferenceSeries Ltd "5th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" held on July 27-28, 2015 in Brisbane, Australia, This will be the latest in the Conference Series annual vaccine meeting series with 500+ Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas & establish business and research collaborations. Opportunities are there for the reseachers present at the meeting to publish their manuscripts/full-length papers based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference Series International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ upcoming and previous symposiums and workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With members from around the world focused on learning about Vaccinology/Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology/Vaccine community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology/Vaccinology are hallmarks of this conference.
Target Audience:
- Vaccinology/Immunology Students, Scientists
- Vaccinology/Immunology Researchers
- Vaccinology/Immunology Faculty
- Medical Colleges
- Vaccinology/Immunology Associations and Societies
- Business Entrepreneurs
- Training Institutes
- Software developing companies
- Manufacturing Medical Devices Companies
- Data Management Companies
- Machinery Manufacturing Companies
Summary:
Vaccine is a biological mixture which contains microorganism and is often made up of weekend or killed forms of the microorganism which provide acquired immunity to a particular disease. When vaccines administered to the body, antigens of the vaccine stimulate the immune system of the body which causes the production of antibodies. Edward Jenner discovered the first vaccine to treat small pox way back in 18th century since from that the basics of vaccines were started to get explored. Since then, there had been massive changes in technologies, which had made it possible to developed vaccines for against diseases: TB, Polio, Tetanus, Chickenpox, and Measles etc. Research for DNA Vaccine is going on. Scientist believed that DNA Vaccines have highest probability to fight with diseases. Childhood vaccination is safe because it’s given to child in early age so the adverse effects are probably less. Vaccines may have some adverse effects like fever, pain on the site of injection. Muscle aches. Vaccines are not used only for human, veterinary vaccines are also there to treat animals. Limitation of vaccines may be there but vaccines have been the most effective means to fight and eradicate infectious diseases.
Importance & Scope:
Vaccines Congress 2017 highlights the theme “Discussion on technologies, advances and challenges related to Vaccines”. Vaccines Congress-2017 is a scientific event designed in such a manner to provide an elite platform for new researchers, scholars, doctors, Immunologist, pathologist, students related to vaccine to present and talk over the most recent innovations, advances, developments, and practical challenges and the solutions adopted in the concerned area. The two days scientific programmes include keynote presentation, speaker presentation, and poster presenters, workshop on the latest in innovative methods as well as papers in the area of Vaccine technology, Immunology and Pathology, Biotechnology.
Demands for Vaccines are increasing in billion dollars as the vaccines safety , vaccine efficacy are developing with new technology, advancements and product improvement which are hoped to meet the unfulfilled requirements of different vaccines market globally. Vaccines are preparation of complex molecules with diverse clinical characteristics. Now transgenic plants are also used for the preparation of vaccine. According to report vaccine market was about 32.2 billion USD in 2014 and it is expected to grow at a CAGR above 11.0% 2015 - 2020.
Market Research:
Vaccines are therapies used to prevent or cure diseases thereby helping to correct any problems caused by the specific diseases. There are various vaccines like HPV vaccine, Hepatitis-B vaccine, TB Vaccines, Polio Vaccines and Diphtheria etc. The global market of vaccine is mostly depending on the public purchase and donor policies. Individual vaccine market is rapidly changing because different countries introducing new vaccines, and changing their preference for traditional vaccines.
The global market of vaccines is expected to reach 48.03 billion by 2021 from UDD 32.24 billion in 2016 at a CAGR of 8.3%. The global market for vaccine is broadly classified into technology, type, disease indication, end users and regions. Based on type the vaccine is segmented into two categories monovalent and multivalent vaccines. Monovalent vaccines have largest share of the market. Based on the disease indication, pneumococcal infection expected to account for largest share in global market in 2017. As per market research base on type of vaccine conjugate vaccines are occupying the largest share of the vaccines market. Based on disease condition the pneumococcal segment is accounted the highest share of the market in 2017. Paediatric segment is expected to account highest share in global vaccine market based on end users. Based on the region the vaccine market is dominated by North America. As the need of vaccines is increasing many companies are investing in vaccines production. The major companies holding the share of the global market are Astellas Pharma lnc., CLS Limited, GSK, Pfizer, Serum Institute of India etc.
The Vaccine market of USA is expected to reach USD 17.4 billion in 2018, at a CAGR of 5.3% from 2012- 2018. 80% of USA vaccine market occupies by the human vaccines. USA market will be continue to lead the global vaccines market due to rising in the disease condition in humans and animals.
There are wide scopes in vaccine field from its production to administration that is why its market is also increasing. Different types of vaccines are there like inactivated, attenuated, toxoid, subunit and conjugate so there are multiple technologies existing for vaccine production (e.g. egg based vaccine, cell based vaccine etc.). Now vaccine adjuvants are also in use which boosts the immune response of the vaccine. So the market for the vaccine vaccines as well the materials related to vaccines are increasing. A major factor which is helping the vaccine market is disease condition. For the changes in environment, life style most of the population affecting by different diseases, Immunotherapy or vaccine therapy now a days taking the first place to fight against this disease there for the industries investing for the vaccine research, vaccine production.
With the leading technologies vaccine delivery, its production gets developed. Vaccine safety also increases day by day. Science developed to fight the most critical disease like cancer with the help of vaccine therapy. The chances and scopes are growing widely for vaccine research.
Why Chicago?
Chicago is the third most populous city in US over 2.7 million residents, it is in the state of Illinois. Chicago was incorporated as a city in the year of 1837, nearby the portage between the Great Lakes and the Mississippi River. The city is international hub for industry, finance, technology, commerce telecommunication and transportation. By the Globalization and World Cities Research Network Chicago was listed as an alpha global city in the year of 2012. In 2014 Global Cities Index Chicago ranked seventh. Chicago ha the third largest gross metropolitan products in the US about $630.3 billion according to 2014-2016 estimate. The city been also rated for most balanced economy in USA. Chicago’s waterfront and nightlife attracted tourism. The literature of Chicago is writing. Renowned universities are here in Chicago. Different biotech, pharmaceutical and vaccine conferences are there in Chicago.
Sensing the raising importance of Vaccines, Conference series LLC International hosted the
26th International Conference on Travel Medicine, Vaccines & Therapeutics, scheduled from October 05-06, 2017, in Chicago, USA with a theme “Harnessing the Global Innovations in vaccines, Therapeutics and Healthcare for the better future”. Benevolent response and active participation was received from the Editorial Board Members of ConferenceSeries Ltd Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.
The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:
- Infectious Diseases Types
- Ebola, Arboviral diseases and Haemorrhagic Fever
- Causes and Symptoms of Infectious Diseases
- Business People Investment Meet
- Immunization for Emerging and Communicable Diseases
- Global policy/Regulations for Disease prevention and control
- Global Trends in Emerging Infectious Diseases
- Global Market on Infectious Diseases
- Animal and Tick-borne Infections
- Vaccines Against infectious & Non Infections diseases
- Allergies and skin diseases in Traveller - Vaccinations
- Malaria sickness in and Treatment
- Diarrhea and other Gastrointestinal Disorders
- Rubella Vaccines
The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;
Magdalena Tary-Lehmann, Case Western Reserve University School of Medicine, USA
Jorge Alberto Panameno Pineda, Fundación Salvadoreña para la Inmunoinfectologia y
Medicina Tropical, USA
Giulio Filippo Tarro Foundation de Beaumont Bonelli for Cancer Research, Italy
Kei Numazaki, International University of Health and Welfare, Japan
Michele Stone, University of Maryland, USA
Conference Series offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced in supporting and making the conference as never before one.
Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Global Vaccines Congress 2016, is delighted to announce the next event. Mark your calendars for the upcoming extravaganza," 26th International Conference on Travel Medicine, Vaccines & Therapeutics”October 05-06, 2017 Chicago, USA.
Vaccines Asia Pacific-2015
Sensing the raising importance of Vaccines, Conference series LLC International hosted the 5th Asiapacific Global Summit and Expo on Vaccines & Vaccination” (Vaccines Asiapacific-2015), scheduled from July 27-29, 2015 in Brisbane, Australia with a theme “Vaccine Research: From Bench to Bedside”. Benevolent response and active participation was received from the Editorial Board Members of ConferenceSeries Ltd Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.
The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:
- Technologies for the Design, Discovery, formulation and administration of vaccines.
- Developing Next-Gen Conjugate Vaccines.
- New trends in carbohydrate-based vaccines.
- Vaccines for Pregnant Women.
- Recent advances in animal vaccination
- Adjuvants for human vaccines—current status, problems and future prospects.
- Current developments in bacterial conjugate vaccines potency.
- Recent trends in attenuated vaccines.
- Advancements in vaccine development
- Vaccination and quality of life
- Protein subunits- vaccination.
- Toxoid vaccines and its importance
- Geriatric Immunization
- Vaccines under research and development, major diseases
- Innovative development of vaccines
The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;
Dr. Nikolai Petrovsky, Flinders University, Australia
Dr. Roy Hall, The University of Queensland, Australia
Dr. Jan Fohlman, Växjö and Uppsala University, Sweden
Dr. Istvan Toth, The University of Queensland, Australia
Young Researchers:
Towards the development of oral vaccine delivery systems for lipid core peptide-based vaccines using novel multi-layer engineered nanoliposomes against Group A streptococcus
Nirmal Marasini, The University of Queensland, Australia
Title: A Protective Immune Response Using Asymmetric Multi-Epitope Self-Adjuvanting lipopeptide Vaccine Model
Sharareh Eskandari, The University of Queensland, Australia
Title: Binding and immune modulation properties of mannosylated lipo-peptide vaccines
Bita Sedaghat, The University of Queensland, Australia
Title: Liposomes as a Delivery Platform of Vaccines Against Group A Streptoccocus
Khairunnisa Abdul Ghaffar, University of Queensland, Australia
Conference Series offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced in supporting and making the conference as never before one.
Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Asiapacific-2015, is delighted to announce the next event. Mark your calendars for the upcoming extravaganza," 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination" to be held during October 17-19, 2016 Kuala Lumpur, Malaysia.
For More details: http://vaccines.global-summit.com/asia-pacific/2015/
The 4th International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS International. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:
Overview
http://www.conferenceseries.com/immunology-conferences.php
• Vaccines and the Basic Immune System
• New Approaches for B and T Cells
• Cellular and Molecular-Based Vaccines
• Vaccines Against Infectious Diseases
• Manufacturing, Production and Development of Vaccines
• Regulatory and Ethical Issues of Vaccines and Public Acceptance
• Current Issues on Clinical Evaluation and Field Trials of Vaccines
• Modern Technologies in Vaccine Discovery and Development
• Age-Specific Immune Response to Vaccination
• Novel Delivery technologies in Vaccines and many more...
The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about 550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
Jeffrey B Ulmer, Novartis Vaccines USA
Ray Spier, Former President, International Society for Vaccines, UK
Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2014.
All accepted abstracts have been indexed in OMICS International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.
Conference Proceedings
Sponsors and exhibitors
Sanofi Pasteur SA
U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370
Vaccinogen Inc.,
5300 West view Dr # 406, Frederick, MD 21703, United States
Cellular Technology Limited (CTL)
North & South America
CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,
Gen Phar
600 Seacoast Pkwy # 100,
Mt Pleasant, SC 29464, United States
OMICS International, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by OMICS International, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.
Highlights of Annual Global Vaccines Conferences-OMICS International
• Keynote forum
• Exhibitions
• Company Presentations
• Speaker Forum
• Workshops and Symposia’s
• B2B Meetings
• One to One meeting
• Special Session for Students
• Scientific writing
• Journal review
• Grant writing
• Strategies for building a scientific career
• Scientific careers outside of research
• Company Promotions
• Young Research Forum
• Best Poster Awards
• Certification by the “International Organizing committee” and many more...
The 2nd International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from OMICS International. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following
Scientific tracks:
• Vaccines and the Basic Immune System
• New Approaches for B and T Cells
• Cellular and Molecular-Based Vaccines
• Vaccines Against Infectious Diseases
• Manufacturing, Production and Development of Vaccines
• Regulatory and Ethical Issues of Vaccines and Public Acceptance
• Current Issues on Clinical Evaluation and Field Trials of Vaccines
• Modern Technologies in Vaccine Discovery and Development
• Age-Specific Immune Response to Vaccination and many more...
Conference Proceedings
The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about 300 attendies representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
De-Chu Christopher Vaxin Inc., USA
John Dong GenPhar, USA
Donald E. Greydanus Western Michigan University School of Medicine, USA
Eli Young OpSaniTx, USA
Takashi Kei Kishimoto Selecta Biosciences, USA
Daniel H Zimmerman CEL-SCI Corporation, USA
Gerardo Kaplan FDA, USA
Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA
Haval Shirwan University of Louisville, USA and many more.
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions at Vaccines-2012.All accepted abstracts have been indexed in OMICS International- Journal of Vaccines & Vaccination as a specialissue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.
Vaccines-2011 Conference Report
The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November
22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by OMICS Group brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.
Conference highlighted the following topics:
• Vaccines and the basic immune system
• New approaches for B and T cells
• Cellular and molecular-based vaccines
• Vaccines against infectious diseases
• Therapeutic vaccine manufacturing, production and development
• Logical and ethical issues and vaccines
• Experimental and clinical evaluation of therapeutic vaccines
• Basic Vaccinology and modern vaccine discovery technologies and many more...
The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with
aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and
strategies of Vaccines and Vaccination.
We take an immense pleasure in thanking our Keynote Speakers:
Gary Alan Flory Virginia Department of Environmental Quality, USA
Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA
Kei Amemiya US Army Medical Research Institute, USA
Edmund J. Gosselin Albany Medical College, USA
Mansour Mohamadzadeh University of Florida, USA and many more...
Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.
Conference Proceedings
We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the overwhelming response and suggestions and feedbacks from our previous attendees. OMICS International is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.
Conference Highlights
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
| Conference Date | October 30-31, 2017 | ||
| Sponsors & Exhibitors |
|
||
| Speaker Opportunity Closed | |||
| Poster Opportunity Closed | Click Here to View | ||
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by